Abstract
Coronary heart disease is a leading cause of death worldwide, causing a reduction in blood flow that leads to damage of heart tissue. Much of this damage occurs via opening of the mitochondrial permeability transition pore (MPTP). Preventing this pore's opening is therefore a useful therapeutic goal in treating cardiovascular disease. Hydroxysafflor yellow A (HSYA, a yellow principle from the safflower, Carthamus tinctorius) has been proposed as a nontoxic alternative to other agents which reduce MPTP opening. In this study, we proposed that HSYA prevents MPTP formation/opening in anoxic cardiac myocytes, and thus should protect the cells from morphologic changes seen during reoxygenation. We used isolated cardiac myocytes in an established anoxia/reoxygenation protocol to examine the cardioprotective potential of both HSYA and cyclosporine A (CsA, an agent known to inhibit MPTP formation). HSYA moderated both the reduction of viability and the loss of rods which attend anoxia and reoxygenation. The pattern of HSYA's protective effect was similar to that of CsA. The appearance of rigor forms (dependent on ATP/ADP, not calcium or MPTP opening) was unaffected by either agent. Experiments with HSYA transport indicate that roughly 50% of extracellular HSYA crosses the cell membrane in a 2-hour incubation (i.e., enough to have an effect). We conclude that HSYA can successfully enter the cardiac myocyte, and is able to moderate anoxia/reoxygenation- induced damage by interacting with the MPTP.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.